Search

everythinglearnresearchcommunity

for

Search:↓

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Proper hygiene, adequate sleep, and self-care can reduce common skin diseases.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Air Vice-Marshal Sir Ralph Jackson significantly advanced dialysis technology in the UK.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Astragalus sinicus extracts may help promote hair growth and treat hair loss.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Anabolic steroid users may face higher risk of severe COVID-19.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The treatment might help COVID-19 related hair loss, but more research is needed.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.